Study to Assess Efficacy and Safety of Dupilumab in the Treatment of Keloids

Condition:   Keloid Intervention:   Drug: Dupilumab Sponsors:   Beth Israel Deaconess Medical Center;   Regeneron Pharmaceuticals Not yet recruiting

Source: ClinicalTrials.gov - November 22, 2021 Category: Research Source Type: clinical trials